Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
S-8
Registration of securities for employees
4 Apr 24
424B4
Prospectus supplement with pricing info
3 Apr 24
EFFECT
Notice of effectiveness
3 Apr 24
POS AM
Prospectus update (post-effective amendment)
1 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
1 Apr 24
8-K
Other Events
18 Mar 24
424B5
Prospectus supplement for primary offering
18 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 Feb 24
8-K
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
13 Feb 24
8-K
Cingulate Announces Pricing of $7.5 Million Public Offering
7 Feb 24
424B4
Prospectus supplement with pricing info
5 Feb 24
EFFECT
Notice of effectiveness
5 Feb 24
CORRESP
Correspondence with SEC
30 Jan 24
CORRESP
Correspondence with SEC
30 Jan 24
S-1/A
IPO registration (amended)
29 Jan 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
UPLOAD
Letter from SEC
18 Jan 24
S-1
IPO registration
12 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Dec 23
8-K
Departure of Directors or Certain Officers
15 Dec 23
8-K
Departure of Directors or Certain Officers
12 Dec 23
RW
Registration withdrawal request
6 Dec 23
8-K
Material Modifications to Rights of Security Holders
28 Nov 23
S-1
IPO registration
15 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
13 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
3 Nov 23
8-K
Cingulate to Host CNS Key Opinion Leader Panel in New York City
19 Oct 23
DEF 14A
Definitive proxy
2 Oct 23
PRE 14A
Preliminary proxy
22 Sep 23
424B4
Prospectus supplement with pricing info
12 Sep 23
EFFECT
Notice of effectiveness
12 Sep 23
8-K
Entry into a Material Definitive Agreement
11 Sep 23
S-1/A
IPO registration (amended)
7 Sep 23
CORRESP
Correspondence with SEC
7 Sep 23
Latest ownership filings
SC 13D/A
Werth Peter J.
12 Apr 24
4
Peter J. Werth
12 Apr 24
4
Raul R. Silva
1 Apr 24
4
Matthew Brams
1 Apr 24
4
Peter J. Werth
27 Mar 24
4
Jennifer L. Callahan
22 Mar 24
4
Shane J. Schaffer
6 Mar 24
4
JOHN A ROBERTS
6 Mar 24
4
Peter J. Werth
6 Mar 24
4
Jeffrey S Ervin
6 Mar 24
4
Raul R. Silva
6 Mar 24
4
Bryan Jay Lawrence
6 Mar 24
4
Matthew Brams
6 Mar 24
4
Jennifer L. Callahan
6 Mar 24
4
Laurie Myers
6 Mar 24
SC 13D/A
Werth Peter J.
28 Feb 24
3
Bryan Jay Lawrence
14 Feb 24
3
Jeffrey S Ervin
14 Feb 24
SC 13G
Lind Global Fund II LP
9 Feb 24
SC 13D/A
Werth Peter J.
9 Feb 24
SC 13D/A
Werth Peter J.
29 Jan 24
4
Peter J. Werth
29 Jan 24
SC 13D/A
Werth Peter J.
4 Jan 24
SC 13D/A
Schaffer Shane J.
4 Jan 24
4
Raul R. Silva
2 Jan 24
SC 13D/A
Werth Peter J.
8 Nov 23
4
Raul R. Silva
2 Oct 23
4
Jennifer L. Callahan
18 Sep 23
SC 13D/A
Schaffer Shane J.
18 Sep 23
SC 13D/A
Werth Peter J.
18 Sep 23
4
Peter J. Werth
11 Sep 23
SC 13D/A
Werth Peter J.
14 Aug 23
4
Peter J. Werth
14 Aug 23
3
Initial statement of insider ownership
14 Aug 23
SC 13D/A
Werth Peter J.
25 Jul 23
SC 13D/A
Schaffer Shane J.
25 Jul 23
SC 13G/A
Brams Matthew
25 Jul 23
4
Raul R. Silva
3 Jul 23
4
GREGG WM GIVENS
20 Jun 23
4
Patrick Joseph Gallagher
20 Jun 23